Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye
Open Access
- 24 April 2018
- journal article
- case report
- Published by Wiley in Case Reports in Ophthalmological Medicine
- Vol. 2018, 1-4
Abstract
Intravitreal injections of antivascular endothelial growth factor (anti-VEGF) agents have been reported to occasionally produce a therapeutic effect in the uninjected fellow eye. Here, three patients with bilateral neovascular age-related macular degeneration are presented. In all three patients, unilateral anti-VEGF injection resulted in bilateral reduction of macular thickness as measured by spectral domain optical coherence tomography.Keywords
Funding Information
- National Institutes of Health (P30EY014801)
- Research to Prevent Blindness (P30EY014801)
This publication has 19 references indexed in Scilit:
- Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurityGraefe's Archive for Clinical and Experimental Ophthalmology, 2017
- Current advances in the treatment of neovascular age-related macular degenerationExpert Opinion on Drug Delivery, 2016
- Reduction of Diabetic Macular Edema in the Untreated Fellow Eye Following Intravitreal Injection of AfliberceptOphthalmic Surgery, Lasers and Imaging Retina, 2016
- The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFsOman Journal of Ophthalmology, 2016
- Progression to macula-off tractional retinal detachment after a contralateral intraoperative intravitreal bevacizumab injection for proliferative diabetic retinopathyClinical Ophthalmology, 2015
- Protective factors in diabetic retinopathy: focus on blood-retinal barrier.2014
- Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMDBritish Journal of Ophthalmology, 2014
- Effects of Intravitreally Injected Bevacizumab on Vascular Endothelial Growth Factor in Fellow EyesJournal of Ocular Pharmacology and Therapeutics, 2011
- Lack of Therapeutic Effect of Ranibizumab in Fellow Eyes After Intravitreal AdministrationJournal of Ocular Pharmacology and Therapeutics, 2010
- Bilateral response following unilateral intravitreal bevacizumab injection in a child with uveitic cystoid macular edemaJournal of American Association for Pediatric Ophthalmology and Strabismus, 2009